Involvement of cancer-derived EMT cells in the accumulation of
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 05 2021
17 05 2021
Historique:
received:
13
01
2021
accepted:
06
04
2021
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
3
11
2021
Statut:
epublish
Résumé
A high rate of glycolysis, one of the most common features of cancer, is used in positron emission tomography (PET) imaging to visualize tumor tissues using
Identifiants
pubmed: 33994540
doi: 10.1038/s41598-021-88414-1
pii: 10.1038/s41598-021-88414-1
pmc: PMC8126561
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9668Références
Clin Cancer Res. 2004 Apr 1;10(7):2245-52
pubmed: 15073099
Sci Rep. 2018 Aug 7;8(1):11817
pubmed: 30087375
Medicina (Kaunas). 2018 May 15;54(2):
pubmed: 30344262
Cancer Chemother Pharmacol. 2017 May;79(5):855-861
pubmed: 28331985
Oncotarget. 2017 May 19;8(42):73219-73239
pubmed: 29069865
BMC Med Imaging. 2017 Jan 5;17(1):1
pubmed: 28056868
Front Oncol. 2018 Jul 23;8:271
pubmed: 30083516
Hum Pathol. 2018 Sep;79:1-8
pubmed: 29555579
Trends Cell Biol. 2017 Nov;27(11):863-875
pubmed: 28734735
Cancer Discov. 2012 Oct;2(10):922-33
pubmed: 22956644
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8782-8
pubmed: 16361566
Anat Rec (Hoboken). 2017 Dec;300(12):2184-2191
pubmed: 28921916
Eur J Nucl Med. 2000 Dec;27(12):1778-85
pubmed: 24578007
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
J Nucl Med. 1986 Feb;27(2):235-8
pubmed: 3712040
Pharmacol Res. 2019 Dec;150:104511
pubmed: 31678210
J Cancer. 2018 Oct 5;9(21):3839-3849
pubmed: 30410586
Oncotarget. 2017 May 25;8(34):57813-57825
pubmed: 28915713
Nat Rev Drug Discov. 2019 Feb;18(2):99-115
pubmed: 30470818
Mol Cell Biol. 2001 May;21(10):3436-44
pubmed: 11313469
Medicine (Baltimore). 2016 Feb;95(5):e2772
pubmed: 26844524
Med Oncol. 2014 Jun;31(6):970
pubmed: 24781336
Physiol Rev. 2011 Jul;91(3):1071-121
pubmed: 21742796
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):674-685
pubmed: 28213330
Mol Cancer. 2019 Mar 30;18(1):70
pubmed: 30927908
J Nucl Med. 2012 Aug;53(8):1262-8
pubmed: 22717978
Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38
pubmed: 23506862
Genes Dev. 1998 Jan 15;12(2):149-62
pubmed: 9436976
Eur J Med Chem. 2018 Jul 15;155:316-336
pubmed: 29902719
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Theranostics. 2018 Feb 2;8(5):1376-1388
pubmed: 29507627
Radiology. 1993 Dec;189(3):847-50
pubmed: 8234714
Oncotarget. 2017 Jun 27;8(26):43536-43542
pubmed: 28402949
Theranostics. 2016 Jan 01;6(1):118-30
pubmed: 26722378
Front Oncol. 2019 Dec 12;9:1399
pubmed: 31921656
J Cell Biol. 1962 Nov;15:173-88
pubmed: 14018772
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
J Nucl Med. 2009 Feb;50(2):266-73
pubmed: 19164236
Radiother Oncol. 2018 Apr;127(1):36-42
pubmed: 29273260
PLoS One. 2012;7(11):e49766
pubmed: 23185433
Int J Biochem Cell Biol. 2019 Jun;111:12-18
pubmed: 30278227
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
J Surg Res. 2018 Dec;232:621-628
pubmed: 30463782
J Nucl Med. 2004 Mar;45(3):455-60
pubmed: 15001687
Oncogenesis. 2018 Jan 24;7(1):10
pubmed: 29362402
Nucl Med Biol. 2005 Oct;32(7):719-25
pubmed: 16243647
Lung Cancer. 2016 Oct;100:14-19
pubmed: 27597275
J Nucl Med. 2017 Apr;58(4):523-532
pubmed: 28232605
BMC Cancer. 2010 Jun 03;10:255
pubmed: 20525277
Anticancer Res. 2018 Oct;38(10):5909-5916
pubmed: 30275218
J Nucl Med. 2012 May;53(5):701-8
pubmed: 22496583